Intra-Cellular Therapies, Inc.

ITCI US46116X1019

🆔
Registration No.
5391614
💰
Capitalization
Mid-cap

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

🔗
Website
https://www.intracellulartherapies.com
Annual Performance 1
2021 2022 2023 2024 2025
65% 2% 39% 18% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
107
🙍
Insiders
8
Person Price Shares Total Published Completed
Mates Sharon
CEO 		84.06
USD 		50,163
Sold 		4,216,928
USD 		04/12/2024 05/12/2024
Mates Sharon
CEO 		84.69
USD 		1,534
Sold 		129,914
USD 		04/12/2024 05/12/2024
Mates Sharon
CEO 		85.62
USD 		27,667
Sold 		2,368,909
USD 		04/12/2024 04/12/2024
Mates Sharon
CEO 		86.00
USD 		23,333
Sold 		2,006,750
USD 		04/12/2024 04/12/2024
Halstead Michael
PR 		88.92
USD 		5,343
Sold 		475,100
USD 		12/11/2024 13/11/2024
Halstead Michael
PR 		88.17
USD 		13,371
Sold 		1,178,921
USD 		12/11/2024 13/11/2024
Halstead Michael
PR 		88.72
USD 		15,105
Sold 		1,340,116
USD 		12/11/2024 12/11/2024
Halstead Michael
PR 		90.89
USD 		1,648
Sold 		149,787
USD 		12/11/2024 12/11/2024
Halstead Michael
PR 		89.63
USD 		6,116
Sold 		548,177
USD 		12/11/2024 12/11/2024
Mates Sharon
CEO 		73.32
USD 		6,193
Sold 		454,091
USD 		29/08/2024 30/08/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Intra-Cellular Therapies, Inc. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
6% 8% 29% 28% 290% 425% 56%
Last 52W Low 52W High All-Time Low All-Time High β
131.87 73.84 131.92 7.26 131.92
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Mates Sharon 38 50,531,010.30 1,329,763.43 16/01/2024 05/12/2024
Halstead Michael 19 12,419,320.13 653,648.43 13/11/2023 13/11/2024
Durgam Suresh K. 14 7,154,822.66 511,058.76 13/12/2023 11/03/2024
Neumann Mark 14 6,470,166.83 462,154.77 06/11/2023 16/08/2024
Hineline Lawrence J. 14 3,213,145.16 229,510.37 02/02/2024 11/03/2024
Van Nostrand Robert L 4 2,976,849.31 744,212.33 27/02/2024 18/06/2024
Marcus Joel S 3 1,808,253.39 602,751.13 26/02/2024 26/02/2024
Riggs Rory B 1 337,193.34 337,193.34 24/06/2024 24/06/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.